Stock News & Analysis

So long as Broadcom is making money, does it really matter where the money is coming from?

Sitting in traffic could become a thing of the past with aerial ride-sharing services, and Joby and Archer Aviation are two companies leading the charge.

Don't expect your net worth to approach President Trump's anytime soon.

Expense ratios remain among the lowest in the industry, while sector allocations and risk profiles differ sharply between these two core portfolio options.

Meta's AI spending has Wall Street nervous, but its advertising machine may already be showing why the payoff could be bigger than investors expect.

This under-the-radar semiconductor company is playing a critical role in the artificial intelligence revolution.

Portfolio concentration and sector exposure set these funds apart for investors seeking targeted aerospace and defense strategies.

As a global leader in modular flooring, this furnishings firm reported a notable insider sale amid steady transaction patterns.

HPE shares have more than doubled in 2026.

They have historically beaten the market, and they aren't done yet.

Explore how portfolio composition and sector weightings set these ETFs apart, offering distinct approaches for international diversification.

E.l.f. Beauty and Vita Coco are building the kind of durable growth stories investors can hold for decades.

Or should you wait for a better entry point?

Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.

After a monster 623% trailing 10-year total return, investors are wondering what this popular exchange-traded fund can do in the future.

This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?

The space economy stock is going through major ups and downs along with the rest of the industry.

You may have options you didn't know existed.

Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.

Expense ratios and dividend yields set these tech ETFs apart, while portfolio composition reveals key differences in sector exposure and income potential.